Orbital adnexal lymphoma

Timothy John Sullivan, Kevin Whitehead, Richard Williamson, David Grimes, David Schlect, Ian Brown, Graeme Dickie, Sudershan Bhatia, Arnold C. Paulino, John M. Buatti, Nina A. Mayr, B. Chen Wen, Chelsea C. Pinnix, Bouthaina S. Dabaja, Sarah A Milgrom, Grace L. Smith, Zeinab Abou, Loretta Nastoupil, Jorge E Romaguera, Francesco TurturroNathan Fowler, Luis Fayad, Jason Westin, Sattva Neelapu, Michelle A Fanale, Maria A. Rodriguez, Fredrick B Hagemeister, Hun Ju Lee, Yasuhiro Oki, Michael Wang, Felipe Samaniego, Linda Chi, Bita Esmaeli

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Primary ocular adnexal lymphoma is typically indolent, and patients can experience a complete response with low risk of relapse with low-dose radiotherapy. The following manuscripts review the clinical features and provide strong evidence that guides the current treatment paradigm for this disease.

Original languageEnglish (US)
Title of host publicationFoundational Papers in Oculoplastics
PublisherSpringer International Publishing
Pages375-388
Number of pages14
ISBN (Electronic)9783030927943
ISBN (Print)9783030927936
DOIs
StatePublished - Jan 31 2022

Keywords

  • Cancer
  • Lymphoma
  • Ocular adnexal lymphoma
  • Orbital lymphoma
  • Orbital malignancy
  • Orbital tumor

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Orbital adnexal lymphoma'. Together they form a unique fingerprint.

Cite this